D J Luchins1, D Klass, P Hanrahan
1Department of Psychiatry, University of Chicago, IL 60637, USA. danl@yoda.bad.uchicago.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study found that most patients with schizophrenia or schizoaffective disorder continued risperidone treatment. A slower dose titration and smaller dose increments improved treatment continuation rates.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: